KUALA LUMPUR: My E.G. Services Bhd has announced an at-home, saliva-based Covid-19 testing service for the Philippines. The method is safe and non-invasive, and is aimed at helping the country's fight against the pandemic by accelerating and enhancing screening, it said in a statement. The diagnostic kit enables the on-site collection of saliva samples at home or at the workplace by licensed medical professionals. Samples are then sent to partner laboratories for processing, with test results delivered within one to two working days. The kit has received the approval of the Food and Drug Administration in the Philippines, as well as by authorities in Singapore and Indonesia. According to MYEG, the kit is also capable of detecting the new strains of Covid-19 reported in the UK, South Africa and Brazil. MyEG is the exclusive distributor of the kit, the first of its kind in the Philippines, via its joint venture I-Pay MYEG Philippines Inc in collaboration with IP Biotech Inc and Family Vaccine and Specialty Clinics Inc. "This new approach being introduced by MYEG will not only make testing much more accessible, but will also ensure better protection for people and frontline healthcare providers by reducing the need for close contact since samples can be collected in the comforts and safety of home or within the confines of the workplace. "This fast, convenient and non-invasive method of testing can greatly enhance early accurate detection and subsequent early intervention, which would in turn be instrumental in containing the spread and impact of the COVID-19 virus," it said. MYEG also plans to deploy a similar approach to testing in Malaysia, pending approval from the relevant regulator for the use of the test kits.